Albine Martin

Accelevir Diagnostics, Llc

$3,274,347

Attributed

$6,548,693

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2020–25

$2M$1.5M$1M$500K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,548,693 · 4

By mechanism

U24$4,893,393 · 1

R43$900,000 · 2

R24$755,300 · 1

Top collaborators

Gregory Michael Laird9 shared

Others in their field

Other Emerging Leaders on “Viral”

Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$160,855,334
Leonard Freedman · Leidos Biomedical Research, Inc.$68,911,178
John Damon Chodera · Sloan-Kettering Inst Can Research$51,025,260
Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
Thomas Denny · Duke University$37,546,967

Research focus

ViralAnti-Retroviral AgentsPharmaceutical PreparationsSuccessImmune SystemCellsHiv-1MolecularRetroviridaeSamplingLeftDiagnosticPerformanceAntiretroviral TherapyAcquired Immunodeficiency SyndromeCd4 Positive T LymphocytesMeasurementFrequenciesDisease RemissionReproducibilityPeripheral BloodProvirusesRestInfection